Breaking News Instant updates and real-time market news.

ICUI

ICU Medical

$144.68

18.72 (14.86%)

, PFE

Pfizer

09:39
10/07/16
10/07
09:39
10/07/16
09:39

ICU Medical price target raised to $160 from $132 at Roth Capital

Roth Capital analyst Chris Lewis raised his price target for ICU Medical (ICUI) to $160 from $132 after the company announced an agreement to acquire Hospira Infusion Systems from Pfizer (PFE) for $1B. The analyst is overall positive on the deal as it removes the long-standing customer concentration overhang and grows ICU Medical into a legitimate pure-play infusion therapy company with a complete product portfolio. The company also preannounced Q3 preliminary results above expectations, he notes. Lewis reiterates a Buy rating on ICU Medical's shares.

ICUI

ICU Medical

$144.68

18.72 (14.86%)

PFE

Pfizer

  • 07

    Oct

  • 01

    Nov

ICUI ICU Medical
$144.68

18.72 (14.86%)

08/09/16
ROTH
08/09/16
NO CHANGE
Target $132
ROTH
Buy
ICU Medical Direct sales momentum continues, says Roth Capital
Roth Capital analyst Chris Lewis says ICU Medical delivered a Q2 beat and raised its 2016 outlook as Direct sales momentum and OEM/Hospira growth continued. Although the company expects an even steeper decline in Hospira over the second half of 2016, the analyst believes ICU Medical is well-positioned to sustain revenue growth on Direct strength and non-Hospira OEM channels, with margin expansion opportunities materializing in 2017. Lewis reiterates a Buy rating on the stock and raised his price target on the shares to $132 from $130.
03/11/16
GABE
03/11/16
INITIATION
GABE
Buy
ICU Medical initiated with a Buy at Gabelli
01/14/16
PIPR
01/14/16
NO CHANGE
Target $129
PIPR
Overweight
Piper views potential Pfizer divestment as neutral for ICU Medical
Piper Jaffray analyst Thomas Gunderson views Bloomberg's report that Pfizer (PFE) may be considering a sale of the infusion pump division of the recently acquired Hospira as neutral for ICU Medical (ICUI). Hospira has traditionally been ICU's largest customer, which has some worrying that if the infusion pumps are sold once again, the business could be at risk, Gunderson tells investors in a research note. He believes, however, that a Pfizer divestment could bring some upside to ICU since the infusion pump business is not in the pharma giant's "wheelhouse." Gunderson keeps an Overweight rating on ICU Medical with a $129 price target.
PFE Pfizer

09/14/16
BMOC
09/14/16
NO CHANGE
BMOC
Pfizer should exceed fiscal 2016 guidance, says BMO Capital
BMO Capital analyst Alex Arfaei says that Pfizer should exceed its fiscal 2016 guidance. The analyst says that Medivation, which Pfizer agreed to acquire, gives Pfizer another growth driver. Additionally, Pfizer has a number of other "high margin specialty drugs," according to the analyst. He says that the stock's dividend yield is "attractive," and he keeps a $40 price target and Outperform rating on the shares.
08/23/16
RHCO
08/23/16
DOWNGRADE
RHCO
Neutral
Medivation downgraded to Neutral from Buy at SunTrust
Medivation (MDVN) has agreed to be acquired by Pfizer (PFE) for $81.50 per share.
08/23/16
PIPR
08/23/16
NO CHANGE
PIPR
Pfizer acquisition 'a good fit strategically,' says Piper Jaffray
After Pfizer (PFE) agreed to buy Medivation (MDVN), Piper Jaffray analyst Richard Purkiss says that Pfizer has obtained Xtandi, "a blockbuster prostate cancer treatment," and "a close-to-market and late-stage pipeline." The analyst thinks that Xtandi's expansion to use in adjuvant prostate cancer could increase its sales by 65%-70%. He keeps a $54 price target and Overweight rating on Pfizer.
08/22/16
GSCO
08/22/16
NO CHANGE
GSCO
Goldman lists companies to be in focus after Medivation deal
After Pfizer (PFE) announced it has agreed to acquire Medivation (MDVN) for $81.50 per share in cash, Goldman Sachs analyst Salveen Richter said he expects a focus on other commercial small-to-mid-cap cancer companies, including Incyte (INCY), Seattle Genetics (SGEN), ARIAD (ARIA) and Exelixis (EXEL). Also noting that Sanofi (SNY), which was pursuing Medivation, has recently suggested an interest in a rare disease transaction up to potentially as large as $20B, he would expect rare disease companies of that size - such as BioMarin (BMRN), Amicus (FOLD) and Ultragenyx (RARE) - to be in focus as well.

TODAY'S FREE FLY STORIES

CE

Celanese

$80.91

0.26 (0.32%)

13:19
12/07/16
12/07
13:19
12/07/16
13:19
Conference/Events
Celanese participates in a conference call with Goldman »

Goldman hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

TSRA

Tessera

$40.35

0.55 (1.38%)

13:17
12/07/16
12/07
13:17
12/07/16
13:17
Conference/Events
Tessera management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

$NYE

NYSE Market Internals

13:16
12/07/16
12/07
13:16
12/07/16
13:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:16
12/07/16
12/07
13:16
12/07/16
13:16
Technical Analysis
NASDAQ market internals summary »

Volume is extremely heavy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$109.95

0.84 (0.77%)

, FOX

21st Century Fox

$27.37

-0.16 (-0.58%)

13:12
12/07/16
12/07
13:12
12/07/16
13:12
Periodicals
Apple in talks with studios about early release movie rentals, Bloomberg says »

Apple (AAPL) is in talks…

AAPL

Apple

$109.95

0.84 (0.77%)

FOX

21st Century Fox

$27.37

-0.16 (-0.58%)

FOXA

21st Century Fox

$27.50

-0.06 (-0.22%)

TWX

Time Warner

CMCSA

Comcast

$68.70

0.02 (0.03%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 13

    Mar

ALR

Alere

$39.70

-0.16 (-0.40%)

13:11
12/07/16
12/07
13:11
12/07/16
13:11
Hot Stocks
Breaking Hot Stocks news story on Alere »

Alere down 10% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$67.45

1.09 (1.64%)

13:10
12/07/16
12/07
13:10
12/07/16
13:10
Hot Stocks
Qualcomm begins commercial sampling of 10nm server processor »

Qualcomm Incorporated,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

ALR

Alere

$39.70

-0.16 (-0.40%)

13:10
12/07/16
12/07
13:10
12/07/16
13:10
Hot Stocks
Breaking Hot Stocks news story on Alere 

Alere trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$14.48

0.23 (1.61%)

13:10
12/07/16
12/07
13:10
12/07/16
13:10
Options
Defensive option play opened in Transocean »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$38.08

2.13 (5.92%)

13:09
12/07/16
12/07
13:09
12/07/16
13:09
Hot Stocks
Breaking Hot Stocks news story on U.S. Steel »

U.S. Steel CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$38.09

2.1375 (5.95%)

13:07
12/07/16
12/07
13:07
12/07/16
13:07
Hot Stocks
Breaking Hot Stocks news story on U.S. Steel »

U.S. Steel CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRDS

Crossroads Systems

$5.45

1.12 (25.87%)

13:07
12/07/16
12/07
13:07
12/07/16
13:07
Hot Stocks
Breaking Hot Stocks news story on Crossroads Systems »

Lloyd Miller III reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

X

U.S. Steel

$37.99

2.04 (5.67%)

13:06
12/07/16
12/07
13:06
12/07/16
13:06
Hot Stocks
U.S. Steel CEO says prior administrations didn't understand trade laws »

The U.S. Steel CEO is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$50.18

0.36 (0.72%)

13:05
12/07/16
12/07
13:05
12/07/16
13:05
Hot Stocks
Arthur J. Gallagher & Co. renews Chip Ganassi Racing partnership for 2017 »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
12/07/16
12/07
13:05
12/07/16
13:05
General news
Treasury Action: it's never too early to be thinking about year-end »

Treasury Action:…

RDS.A

Royal Dutch Shell

$52.59

0.219 (0.42%)

, RDS.B

Royal Dutch Shell

$55.96

0.24 (0.43%)

13:03
12/07/16
12/07
13:03
12/07/16
13:03
Periodicals
Shell signs provisional oil and gasfield agreement with Iran, FT says »

Royal Dutch Shell has…

RDS.A

Royal Dutch Shell

$52.59

0.219 (0.42%)

RDS.B

Royal Dutch Shell

$55.96

0.24 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALR

Alere

$39.70

-0.16 (-0.40%)

, ABT

Abbott

$38.02

-0.4 (-1.04%)

13:00
12/07/16
12/07
13:00
12/07/16
13:00
Hot Stocks
Alere issues statement regarding Abbott lawsuit »

Alere (ALR) issued the…

ALR

Alere

$39.70

-0.16 (-0.40%)

ABT

Abbott

$38.02

-0.4 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PI

Impinj

$29.58

2.1 (7.64%)

, AMZN

Amazon.com

$764.72

5.36 (0.71%)

13:00
12/07/16
12/07
13:00
12/07/16
13:00
Hot Stocks
Impinj continues to advance after Amazon's checkout-free store concept »

Shares of Impinj (PI),…

PI

Impinj

$29.58

2.1 (7.64%)

AMZN

Amazon.com

$764.72

5.36 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$12.72

0.1599 (1.27%)

13:00
12/07/16
12/07
13:00
12/07/16
13:00
Options
Bullish yearend play opened in Ford options »

Bullish yearend play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 10

    Jan

GNC

GNC Holdings

$14.10

-0.1 (-0.70%)

12:59
12/07/16
12/07
12:59
12/07/16
12:59
Hot Stocks
GNC Holdings comments on agreement with DOJ »

GNC Holdings issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$40.03

0.6844 (1.74%)

, TWX

Time Warner

$93.69

-0.206 (-0.22%)

12:55
12/07/16
12/07
12:55
12/07/16
12:55
Periodicals
AT&T CEO defends Time Warner deal at Senate hearing, FT says »

AT&T (T) chairman and…

T

AT&T

$40.03

0.6844 (1.74%)

TWX

Time Warner

$93.69

-0.206 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

SPY

SPDR S&P 500 ETF Trust

$222.42

0.72 (0.32%)

, SPX

S&P 500

$2,219.24

7.01 (0.32%)

12:55
12/07/16
12/07
12:55
12/07/16
12:55
Technical Analysis
S&P 500 breaks to fresh life high »

The index was last at…

SPY

SPDR S&P 500 ETF Trust

$222.42

0.72 (0.32%)

SPX

S&P 500

$2,219.24

7.01 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTK

Flotek

$10.58

-2.53 (-19.30%)

12:51
12/07/16
12/07
12:51
12/07/16
12:51
Hot Stocks
FourWorld says Flotek overstates impact of CnF on well productivity »

FourWorld Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

AON

Aon plc

$114.10

0.89 (0.79%)

, MS

Morgan Stanley

$42.46

-0.05 (-0.12%)

12:47
12/07/16
12/07
12:47
12/07/16
12:47
Periodicals
Aon exploring sale of benefits outsourcing division, Reuters reports »

Aon (AON) is looking into…

AON

Aon plc

$114.10

0.89 (0.79%)

MS

Morgan Stanley

$42.46

-0.05 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUE

Nucor

$66.42

0.835 (1.27%)

12:45
12/07/16
12/07
12:45
12/07/16
12:45
Options
Nucor call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.